Our Dual Lens Approach

BVGH works to solve major global health problems by finding the common ground between the needs of patients in poor countries and the pragmatic needs of companies.

Image
 
Image
  
  

Drug Donated for Treatment of Visceral Leishmaniasis

01/24/2012
 To help alleviate the burden of visceral leishmaniasis, Gilead Sciences struck a deal with the World Health Organization to donate 445,000 vials of liposomal amphotericin B, which is used to treat the devastating disease, during the next five years, The Lancet Infectious Diseases reports. Read more

print